BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 28762137)

  • 21. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.
    Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A
    Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of H3K27me3 immunohistochemistry and combination of NF1 and p16 deletions by fluorescence in situ hybridization in the differential diagnosis of malignant peripheral nerve sheath tumor and its histological mimics.
    Sugita S; Aoyama T; Emori M; Kido T; Takenami T; Sakuraba K; Terai K; Sugawara T; Tsujiwaki M; Hasegawa T
    Diagn Pathol; 2021 Aug; 16(1):79. PubMed ID: 34461930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
    Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
    Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor.
    Zhou W; Du X; Song F; Zheng H; Chen K; Zhang W; Yang J
    Oncotarget; 2016 Apr; 7(16):22234-44. PubMed ID: 26993773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.
    Pekmezci M; Cuevas-Ocampo AK; Perry A; Horvai AE
    Mod Pathol; 2017 Dec; 30(12):1710-1719. PubMed ID: 28776579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation
    Panse G; Mito JK; Ingram DR; Wani K; Khan S; Lazar AJ; Doyle LA; Wang WL
    Histopathology; 2021 Jan; 78(2):321-326. PubMed ID: 32735735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Polycomb Repressive Complex in Malignant Peripheral Nerve Sheath Tumor.
    Zhang X; Murray B; Mo G; Shern JF
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32182803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss.
    Marchione DM; Lisby A; Viaene AN; Santi M; Nasrallah M; Wang LP; Williams EA; Larque AB; Chebib I; Garcia BA; Wojcik JB
    Mod Pathol; 2019 Oct; 32(10):1434-1446. PubMed ID: 31175328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological and prognostic significance of H3K27 methylation status in malignant peripheral nerve sheath tumor: correlation with skeletal muscle differentiation.
    Ito Y; Kohashi K; Endo M; Yoshimoto M; Ishihara S; Toda Y; Susuki Y; Kawaguchi K; Furukawa H; Tateishi Y; Yamada Y; Kinoshita I; Mori T; Yamamoto H; Nakashima Y; Oda Y
    Virchows Arch; 2021 Dec; 479(6):1233-1244. PubMed ID: 34432163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].
    Malerba M; Garofalo A
    Tumori; 2003; 89(4 Suppl):246-50. PubMed ID: 12903608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Malignant peripheral nerve sheath tumor: a clinicopathological analysis].
    Peng W; Gong QX; Fan QH; Liu Y; Song GX; Wei YZ
    Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):924-930. PubMed ID: 37670622
    [No Abstract]   [Full Text] [Related]  

  • 33. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
    Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
    J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant Peripheral Nerve Sheath Tumor.
    James AW; Shurell E; Singh A; Dry SM; Eilber FC
    Surg Oncol Clin N Am; 2016 Oct; 25(4):789-802. PubMed ID: 27591499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers.
    Mustapar N; Zawawi MSF; Tuan Sharif SE
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):699-705. PubMed ID: 32212796
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Oppel F; Ki DH; Zimmerman MW; Ross KN; Tao T; Shi H; He S; Aster JC; Look AT
    Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinicopathologic study on SS18 fusion positive head and neck synovial sarcomas.
    Owosho AA; Estilo CL; Rosen EB; Yom SK; Huryn JM; Antonescu CR
    Oral Oncol; 2017 Mar; 66():46-51. PubMed ID: 28249647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurofibromin specific antibody differentiates malignant peripheral nerve sheath tumors (MPNST) from other spindle cell neoplasms.
    Reuss DE; Habel A; Hagenlocher C; Mucha J; Ackermann U; Tessmer C; Meyer J; Capper D; Moldenhauer G; Mautner V; Frappart PO; Schittenhelm J; Hartmann C; Hagel C; Katenkamp K; Petersen I; Mechtersheimer G; von Deimling A
    Acta Neuropathol; 2014 Apr; 127(4):565-72. PubMed ID: 24464231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
    Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytologic features of malignant peripheral nerve sheath tumor.
    Jiménez-Heffernan JA; López-Ferrer P; Vicandi B; Hardisson D; Gamallo C; Viguer JM
    Acta Cytol; 1999; 43(2):175-83. PubMed ID: 10097706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.